15 Jul 2022
According to a new study, published in The Lancet Healthy Longevity, testosterone therapy in men with hypogonadism does not increase their risk of cardiovascular complications. This is in line with existing advice from the European Medicines Agency and the UK Society for Endocrinology’s treatment guidelines.
Bionic pancreas trial results in positive outcomes in patients with diabetes
22 Sep 2023
Non-alcoholic fatty liver disease risk may be reduced with dietary adjustments
22 Sep 2023
Increased kisspeptin levels associated with polycystic ovarian syndrome
22 Sep 2023
Study reveals link between 'forever chemicals' in everyday products and later puberty
22 Sep 2023
Join the Clinical Committee as a Co-Opted Member
18 Sep 2023
